Cigna Group
XMUN:CGN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240.3
338.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cigna Group
Revenue
Cigna Group
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cigna Group
XMUN:CGN
|
Revenue
$232.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
21%
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$368.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$232.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
21%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
Cigna Group
Revenue Breakdown
Breakdown by Geography
Cigna Group
|
Total Revenue:
195.3B
USD
|
|
United States:
189.8B
USD
|
|
All Other Countries:
4.3B
USD
|
Breakdown by Segments
Cigna Group
|
Total Revenue:
195.3B
USD
|
|
Product:
137.2B
USD
|
|
Network Pharmacy:
67.5B
USD
|
|
Home Delivery And Specialty:
65.7B
USD
|
|
Service:
12.6B
USD
|
|
Other Pharmacy:
9B
USD
|
|
Service, Other:
210m
USD
|
Cigna Group
Glance View
Cigna Group, a prominent global health service company, has carved out a significant niche in the ever-evolving landscape of healthcare and insurance. With roots tracing back to the 1980s, Cigna's mission is to enhance the health, wellness, and peace of mind for its customers through a diverse array of products and services. Today, the company serves millions of customers worldwide, offering a robust portfolio that includes health insurance, disability, life insurance, and managed care solutions. As the healthcare landscape becomes increasingly complex, Cigna stands out through its innovative approach to care coordination and a focus on preventive solutions that address not just the symptoms but the underlying factors affecting health. From an investor's perspective, Cigna Group presents a compelling opportunity. The company has demonstrated strong financial stability and growth potential, underpinned by strategic acquisitions, like the significant purchase of Express Scripts, which expanded its capabilities in pharmacy benefits management. Cigna's commitment to integrating digital technology into healthcare services, alongside its focus on value-based care, positions it well amidst rising healthcare costs and an aging population that demands more personalized care solutions. With a solid track record of revenue growth, consistent shareholder returns, and a forward-thinking leadership team, Cigna Group offers investors a unique blend of resilience, adaptability, and long-term value in an increasingly important sector.
See Also
What is Cigna Group's Revenue?
Revenue
232.6B
USD
Based on the financial report for Sep 30, 2024, Cigna Group's Revenue amounts to 232.6B USD.
What is Cigna Group's Revenue growth rate?
Revenue CAGR 10Y
21%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Cigna Group have been 11% over the past three years , 12% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
